Rebirth of granulocyte transfusions: Should it involve pediatric oncology and transplant patients?

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 6, 1999, Pages 475-478

  Strauss, Ronald G ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Granulocyte transfusions; Infections in oncology and transplant patients; Neutrophil transfusions

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; GRANULOCYTE TRANSFUSION; HUMAN; INFECTION; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0033496626     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199911000-00006     Document Type: Article

References (19)

1. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. New Engl J Med 1997;337:1861-9.
2. Peters BG, Adkins DR, Harrison BR, et al. Antifungal effects of yeast derived rhuGMCSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: A retrospective analysis. Bone Marrow Transplant 1996;18:93-102.
3. Vamvakas EC, Pineda AA. Metaanalysis of clinical studies of efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apheresis 1996;11:19-25.
4. Adkins D, Spitzer G, Johnson M, et al. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: Analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 1997;37:737-48.
5. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993;81:1675-8.
6. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. N Engl J Med 1975;292:761-6.
7. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977;63:548-55.
8. Herzig RH, Herzig GP, Graw RG Jr, et al. Successful granulocyte transfusion therapy for gram-negative septicemia. N Engl J Med 1977;296:701-5.
9. Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977;296:706-11.
10. Winston DJ, Ho WB, Gale RP. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 1982;97: 509-15.
11. Graw RG Jr, Herzig G, Perry S, Henderson ES. Normal granulocyte transfusion therapy. N Engl J Med 1972;287:367-76.
12. Fortuny IE, Bloomfield CD, Hadlock, et al. Granulocyte transfusions: A controlled study in patients with acute nonlymphocytic leukemia. Transfusions 1975;15:548-58.
13. Strauss RG, Hester JP, Vogler WR, et al. A multicenter trial to document the efficacy and safety of a rapidly excreted analogue of hydroxyethyl starch for leukapheresis; With a note on steroid stimulation. Transfusion 1986;26:258-62.
14. Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions: Kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (GCSF) and dexamethasone. Transfusion 1998;38:713-21.
15. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors of granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-71.
16. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
17. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996;88:335-40.
18. Kerst JM, de Haas M, van der School CE, et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: Induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993;82:3265-72.
19. Adkins D, Goodgold H, Hendershott L, et al. Indium-labeled white blood cells apheresed from donors receiving GCSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transpl 1997;19:809-14.